Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
12
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Hepatitis - C 2018 NIDA NIH-18-010 CDC NCHHSTP $990,653
Hepatitis - C 2018 NIDA 5R01DA040488-03 RCT of a social-network oriented mhealth based intervention to increase access and adherence to HCV treatment and HIV viral suppression LATKIN, CARL JOHNS HOPKINS UNIVERSITY MD $658,404
Hepatitis - C 2018 NIDA 1R01DA042982-01A1 The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for HCV Trial HAUKOOS, JASON DENVER HEALTH AND HOSPITAL AUTHORITY CO $652,668
Hepatitis - C 2018 NIAID 5R01AI110577-04 Dynamics of Hepatis C viral RNA-dependent RNA replication JOHNSON, KENNETH UNIVERSITY OF TEXAS, AUSTIN TX $453,213
Hepatitis - C 2018 NIAID 5R01AI078881-08 Collaborative Integration of HCV Molecular Virology and Mathematical Modeling UPRICHARD, SUSAN LOYOLA UNIVERSITY CHICAGO IL $531,387
Hepatitis - C 2018 NIAID 5UM1AI069476-11 The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit GRINSZTEJN, BEATRIZ FUNDACAO OSWALDO CRUZ BRAZIL $773,601
Hepatitis - C 2018 NIAID 5R01AI116943-03 A systematic analysis of small RNA interactions during RNA virus infections RICE, CHARLES ROCKEFELLER UNIVERSITY NY $706,055
Hepatitis - C 2018 NHLBI 5R01HL127174-03 Canonical & non-canonical regulation of the HDL receptor by PDZK1's PDZ domains KRIEGER, MONTY MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $474,167
Hepatitis - C 2018 NIAID 5R01AI114748-04 miRNA-mediated premature T cell aging in vaccine failure during viral infection YAO, ZHI EAST TENNESSEE STATE UNIVERSITY TN $365,000
Hepatitis - C 2018 NIAID 5R21AI127924-02 Ferret cell determinants of hepatitis C virus tropism EVANS, MATTHEW ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $210,972
Hepatitis - C 2018 NIAID 5K08AI121348-03 Elucidating Mechanisms of Treatment Relapse for Interferon-Free HCV Therapy MEISSNER, ERIC MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $199,314
Hepatitis - C 2018 NIAID 5R37AI047365-19 Structure and Function of the Hepatitis C Virus Genome SARNOW, PETER STANFORD UNIVERSITY CA $458,399
Hepatitis - C 2018 NIAID 5R01AI085051-09 Drug Resistance in HCV NS3/4A - Inhibitor binding versus substrate recognition SCHIFFER, CELIA UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $588,464
Hepatitis - C 2018 NIAID 5R01AI108765-05 Novel regulatory mechanisms control IFNL3 expression during HCV infection SAVAN, RAM UNIVERSITY OF WASHINGTON WA $489,206
Hepatitis - C 2018 NIAID 5R01AI127463-02 Mechanisms of hepatic innate immune activation by HCV GALE, MICHAEL UNIVERSITY OF WASHINGTON WA $613,337
Hepatitis - C 2018 NIAAA 5P50AA011999-20 8467 Functional Dissection of EtOH-med Self-renew of Liver Tumor-Int Cells via TLR4 MACHIDA, KEIGO UNIVERSITY OF SOUTHERN CALIFORNIA CA $203,571
Hepatitis - C 2018 NIMHD 5U01MD010614-03 Increasing Uptake of Evidence Based Screening Services though a CHW-led multi-modality program: The South Florida Center for Reducing Health Disparities CARRASQUILLO, OLVEEN UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $486,084
Hepatitis - C 2018 NIGMS 5R01GM116898-03 Function and mechanism of the HCV p7 channel and its therapeutic potential CHOU, JAMES HARVARD MEDICAL SCHOOL MA $462,717
Hepatitis - C 2018 NIAID 5R01AI065256-08 HIV Antiretroviral Therapy and Hepatic Injury SHERMAN, KENNETH UNIVERSITY OF CINCINNATI OH $500,044
Hepatitis - C 2018 NIAID 5R01AI123365-03 Structure and function of Hepacivirus envelope glycoprotein LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $625,625
Hepatitis - C 2018 NIDA 5R01DA003574-34 Risk Factors for AIDS among Drug Users: Getting Close to Zero DES JARLAIS, DON ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $683,768
Hepatitis - C 2018 NIAID 5R01AI099506-05 Modulation of internal ribosome entry by ribosomal protein RPS25 SARNOW, PETER STANFORD UNIVERSITY CA $580,275
Hepatitis - C 2018 NIAID 5R01AI125365-02 Analyses of the Antiviral and Antifibrotic Mechanisms of Action of NS5A and Cyclophilin Inhibitors GALLAY, PHILIPPE SCRIPPS RESEARCH INSTITUTE CA $481,250
Hepatitis - C 2018 NICHD 5R01HD075549-05 INNATE AND ADAPTIVE IMMUNITY TO HCV IN HUMAN PREGNANCY ROSEN, HUGO UNIVERSITY OF COLORADO DENVER CO $286,572
Hepatitis - C 2018 NIAID 5R01AI113923-04 Positive Immune-regulators During Chronic Viral Infections ZUNIGA, ELINA UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $459,066
Hepatitis - C 2018 NIAAA 5K23AA023753-04 Understanding and intervening with heavy drinking among patients with HIV and HCV ELLIOTT, JENNIFER NEW YORK STATE PSYCHIATRIC INSTITUTE NY $199,800
Hepatitis - C 2018 NIDA 5R01DA039072-04 Life Course Investigation of People Who Inject Drugs BOOTH, ROBERT UNIVERSITY OF COLORADO DENVER CO $539,045
Hepatitis - C 2018 NIDA 5K01DA036452-05 Social Networks of Youth who Misuse Prescription Opioids and Risk for HIV/HCV AL-TAYYIB, ALIA DENVER HEALTH AND HOSPITAL AUTHORITY CO $151,618
Hepatitis - C 2018 NIDA 5R01DA016065-15 HCV Disease Management in HIV-HCV Coinfected IDUs SULKOWSKI, MARK JOHNS HOPKINS UNIVERSITY MD $706,389
Hepatitis - C 2018 NIAID 5R01AI116868-03 Spatial Models of Intrahepatic Hepatitis C Virus Propagation in Humans RIBEIRO, RUY LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB NM $814,699
Hepatitis - C 2018 NIAID 5R01AI118916-03 The Host Response to Hepatitis C Virus GALE, MICHAEL UNIVERSITY OF WASHINGTON WA $507,805
Hepatitis - C 2018 NIAID 5R01AI111970-05 Optimizing combination therapy for Hepatitis C virus with pharmacodynamic models BROWN, ASHLEY UNIVERSITY OF FLORIDA FL $1,096,497
Hepatitis - C 2018 NIDA 5R03DA041892-02 Migrant Puerto Rican PWID: The Influence of Acculturation and Enculturation on HIV and HCV Risk Behaviors GELPI-ACOSTA, CAMILA NATIONAL DEVELOPMENT & RES INSTITUTES NY $159,932
Hepatitis - C 2018 NIAID 5R01AI120622-02 RESUBMISSION -R01 AI120622 –Restoration of Immunity and Function with DAA Treatment in HCV infection ROSEN, HUGO UNIVERSITY OF COLORADO DENVER CO $43,343
Hepatitis - C 2018 NIAID 5R01AI110358-04 Mechanisms of HCV Assembly YI, MINKYUNG UNIVERSITY OF TEXAS MED BR GALVESTON TX $387,500
Hepatitis - C 2018 NIAID 5U19AI123862-03 6263 Project 2 - France BAUMERT, THOMAS STANFORD UNIVERSITY CA $216,001
Hepatitis - C 2018 NIAID 5U19AI123862-03 6262 Humoral immunity against hepatitis C in protected subjects FOUNG, STEVEN STANFORD UNIVERSITY CA $511,706
Hepatitis - C 2018 NIAID 5U19AI123862-03 6261 Admin Core FOUNG, STEVEN STANFORD UNIVERSITY CA $42,089
Hepatitis - C 2018 NIA 1R01AG055636-01A1 Use of New Hepatitis C Drugs and Patients' Health Outcomes in Medicare JUNG, JEAH PENNSYLVANIA STATE UNIVERSITY-UNIV PARK PA $472,768
Hepatitis - C 2018 NIDDK 5F30DK112514-02 Hepatitis C virus cell entry host factor requirements and mechanisms CHAMBERS, MATTHEW ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $41,724
Hepatitis - C 2018 NIDA 5R25DA013582-17 Clinical Addiction Research and Education (CARE) Program SAMET, JEFFREY BOSTON MEDICAL CENTER MA $335,631
Hepatitis - C 2018 NINR 5F31NR016200-03 Nurse Case Management to Improve Hepatitis C Linkage to Care and Treatment in HIV Coinfection STARBIRD, LAURA JOHNS HOPKINS UNIVERSITY MD $13,883
Hepatitis - C 2018 NIDA 5R01DA025885-10 Sustainable HIV Risk Reduction Strategies for CJ Systems LEHMAN, WAYNE TEXAS CHRISTIAN UNIVERSITY TX $552,720
Hepatitis - C 2018 NIDA 1R01DA043815-01A1 Reducing morbidity and mortality from overdose, HIV, and hepatitis C in opioid-using persons BRAITHWAITE, RONALD NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $714,928
Hepatitis - C 2018 NIAID 5R01AI087925-08 Molecular determinants of hepatitis C virus assembly LINDENBACH, BRETT YALE UNIVERSITY CT $418,750
Hepatitis - C 2018 NIDDK 5R01DK113645-02 Hepatitis C virus infection and mechanism of liver disease progression RAY, RANJIT SAINT LOUIS UNIVERSITY MO $340,875
Hepatitis - C 2018 NIAID 5R01AI085087-08 Role of Lipids in Hepatitis C Virus Maturation SIDDIQUI, ALEEM UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $387,500
Hepatitis - C 2018 NIDDK 5R01DK112295-02 Identification of Novel Bioactive Lipid Metabolites for Predicting Liver-related Outcomes in Persons Co-Infected with HIV and HCV NAGGIE, SUSANNA DUKE UNIVERSITY NC $386,049
Hepatitis - C 2018 NIGMS 5R35GM118088-03 Enzymes and enzyme complexes in RNA metabolism JANKOWSKY, ECKHARD CASE WESTERN RESERVE UNIVERSITY OH $606,757
Hepatitis - C 2018 NIAID 5R01AI095690-08 Micro-RNA 122 and Chronic Hepatitis C LEMON, STANLEY UNIV OF NORTH CAROLINA CHAPEL HILL NC $380,000
Hepatitis - C 2018 NIAID 5R01AI131688-02 Analysis of immunity, viral adaptation and pathogenesis in a new mouse model of HCV-related rodent hepacivirus infection RICE, CHARLES ROCKEFELLER UNIVERSITY NY $715,770
Hepatitis - C 2018 NIAID 5U19AI088791-08 6463 Administrative Core COX, ANDREA JOHNS HOPKINS UNIVERSITY MD $36,604
Hepatitis - C 2018 NIAID 5U19AI088791-08 6464 Scientific Core COX, ANDREA JOHNS HOPKINS UNIVERSITY MD $279,636
Hepatitis - C 2018 NIAID 5U19AI088791-08 6465 Mechanisms driving breadth of HCV neutralization during repeated control of acute infection in humans RAY, STUART JOHNS HOPKINS UNIVERSITY MD $183,109
Hepatitis - C 2018 NIAID 5U19AI088791-08 6466 Mechanisms of T cell control in repeated HCV infection and innate immune responses that drive them COX, ANDREA JOHNS HOPKINS UNIVERSITY MD $137,360
Hepatitis - C 2018 NIAID 5U19AI088791-08 6467 Project 3: To define the genetic identity of infecting, superinfecting, and reinfecting strains of HCV and the dynamics of virus elimination, replacement or persistence SHAW, GEORGE UNIVERSITY OF PENNSYLVANIA PA $157,619
Hepatitis - C 2018 NIDA 5R01DA040513-03 Increasing Involvement of MSM in the Continuum of Care in Kazakhstan WU, ELWIN COLUMBIA UNIV NEW YORK MORNINGSIDE NY $680,687
Hepatitis - C 2018 NIDDK 5K01DK109025-02 MyD88-dependent B cell dysfunction and autoimmunity during chronic liver disease THAPA, MANOJ EMORY UNIVERSITY GA $100,781
Hepatitis - C 2018 NIAID 5R01AI120733-03 The Impact of HCV Infection on Bone Turnover, Density, and Strength BROWN, TODD JOHNS HOPKINS UNIVERSITY MD $737,374
Hepatitis - C 2018 NCI 5R01CA186566-04 Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC) HASSAN, MANAL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $620,205
Hepatitis - C 2018 NIDDK 5R01DK102883-04 HEPATOCYTE REMODELING BY HEPATITIS C VIRUS RANDALL, GLENN UNIVERSITY OF CHICAGO IL $350,489
Hepatitis - C 2018 NIDDK 5R01DK094652-07 Hepatitis C virus and autophagic response OU, J.-H. JAMES UNIVERSITY OF SOUTHERN CALIFORNIA CA $371,250
Hepatitis - C 2018 NIAID 5R01AI097552-05 Role of Lipid Droplets in Hepatitis C Virus Infection OTT, MELANIE J. DAVID GLADSTONE INSTITUTES CA $477,500
Hepatitis - C 2018 NIDA 5T32DA041898-02 Integrated Care for Addiction, HIV and HCV Research and Education (ICAHRE) DRAINONI, MARI-LYNN BOSTON UNIVERSITY MEDICAL CAMPUS MA $330,443
Hepatitis - C 2018 NIDA 5R01DA044111-02 Long-term Effects of IDU, HIV, HCV and the Impact of HCV Cure on Immune Activation and Liver Fibrosis in Aging Women KOVACS, ANDREA UNIVERSITY OF SOUTHERN CALIFORNIA CA $705,013
Hepatitis - C 2018 NIDDK 5R01DK106244-03 Hepatitus C virus-induced inflammasome and lipid metabolism WARIS, GULAM ROSALIND FRANKLIN UNIV OF MEDICINE & SCI IL $351,000
Hepatitis - C 2018 NIDDK 5R01DK101773-04 Innate Defense Program against HCV SAITO, TAKESHI UNIVERSITY OF SOUTHERN CALIFORNIA CA $371,250
Hepatitis - C 2018 NIDA 5K24DA035684-05 Treatment outcomes and comorbidity in HIV-infected IDU LUCAS, GREGORY JOHNS HOPKINS UNIVERSITY MD $164,685
Hepatitis - C 2018 NIAID 2R44AI124933-03 Development of a kit for the targeted depletion of abundant sequencesfromDNA/RNA libraries CARPENTER, MEREDITH ARC BIO, LLC MA $998,921
Hepatitis - C 2018 NCI 5P30AI036219-24 5313 Clinical Services Core D LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $24,681
Hepatitis - C 2018 NIMHD 5P30AI036219-24 5313 Clinical Services Core D LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $7,672
Hepatitis - C 2018 NHLBI 5P30AI036219-24 5313 Clinical Services Core D LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $17,091
Hepatitis - C 2018 NIA 5P30AI036219-24 5313 Clinical Services Core D LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $2,882
Hepatitis - C 2018 NIAID 5P30AI036219-24 5313 Clinical Services Core D LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $90,778
Hepatitis - C 2018 NICHD 5P30AI036219-24 5313 Clinical Services Core D LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $7,803
Hepatitis - C 2018 NIDA 5P30AI036219-24 5313 Clinical Services Core D LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $12,195
Hepatitis - C 2018 NIDDK 5P30AI036219-24 5313 Clinical Services Core D LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $6,538
Hepatitis - C 2018 NIGMS 5P30AI036219-24 5313 Clinical Services Core D LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $6,538
Hepatitis - C 2018 OD 5P30AI036219-24 5313 Clinical Services Core D LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $10,968
Hepatitis - C 2018 NIDDK 5R01DK109823-03 HIV, HCV and the Menopausal Transition: Effects on Steatosis and Fibrosis Progression TIEN, PHYLLIS NORTHERN CALIFORNIA INSTITUTE/RES/EDU CA $684,328
Hepatitis - C 2018 NIAID 1R01AI136533-01 Dynamics of antigen specific B and Tfh responses during acute and chronic HCV GRAKOUI, ARASH EMORY UNIVERSITY GA $825,277
Hepatitis - C 2018 NIDA 5P30DA040500-04 6227 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (Admin Core) SCHACKMAN, BRUCE WEILL MEDICAL COLL OF CORNELL UNIV NY $298,199
Hepatitis - C 2018 NIDA 5P30DA040500-04 6228 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (Methodology Core) SCHACKMAN, BRUCE WEILL MEDICAL COLL OF CORNELL UNIV NY $318,183
Hepatitis - C 2018 NIDA 5P30DA040500-04 6229 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core) LINAS, BENJAMIN BOSTON MEDICAL CENTER MA $199,888
Hepatitis - C 2018 NIDA 5P30DA040500-04 6230 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (Dissemination Core) MEISEL, ZACHARY UNIVERSITY OF PENNSYLVANIA PA $271,267
Hepatitis - C 2018 NIDA 5P30DA040500-04 6231 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (Pilot Training Core) ADEN, BRANDON WEILL MEDICAL COLL OF CORNELL UNIV NY $66,368
Hepatitis - C 2018 NCI 5P30AI050409-20 7296 Core D: Clinical Research Core OFOTOKUN, IGHOVWERHA EMORY UNIVERSITY GA $64,023
Hepatitis - C 2018 NIMHD 5P30AI050409-20 7296 Core D: Clinical Research Core OFOTOKUN, IGHOVWERHA EMORY UNIVERSITY GA $244,794
Hepatitis - C 2018 NHLBI 5P30AI050409-20 7296 Core D: Clinical Research Core OFOTOKUN, IGHOVWERHA EMORY UNIVERSITY GA $53,205
Hepatitis - C 2018 NIA 5P30AI050409-20 7296 Core D: Clinical Research Core OFOTOKUN, IGHOVWERHA EMORY UNIVERSITY GA $5,212
Hepatitis - C 2018 NIAID 5P30AI050409-20 7296 Core D: Clinical Research Core OFOTOKUN, IGHOVWERHA EMORY UNIVERSITY GA $353,810
Hepatitis - C 2018 NICHD 5P30AI050409-20 7296 Core D: Clinical Research Core OFOTOKUN, IGHOVWERHA EMORY UNIVERSITY GA $24,220
Hepatitis - C 2018 NIDA 5P30AI050409-20 7296 Core D: Clinical Research Core OFOTOKUN, IGHOVWERHA EMORY UNIVERSITY GA $39,977
Hepatitis - C 2018 NIDDK 5P30AI050409-20 7296 Core D: Clinical Research Core OFOTOKUN, IGHOVWERHA EMORY UNIVERSITY GA $14,909
Hepatitis - C 2018 NIGMS 5P30AI050409-20 7296 Core D: Clinical Research Core OFOTOKUN, IGHOVWERHA EMORY UNIVERSITY GA $14,909
Hepatitis - C 2018 NIDA 5R01DA040811-03 A Natural History Study of Buprenorphine Diversion, Self-Treatment, and Use of Drug Abuse Treatment Services DANIULAITYTE, RAMINTA WRIGHT STATE UNIVERSITY OH $581,500
Hepatitis - C 2018 NIDA 1R34DA045544-01 Development and Pilot Testing of a Persuasive Health Communication Intervention for Emergency Department Patients Who Decline Rapid HIV/HCV Screening MERCHANT, ROLAND BRIGHAM AND WOMEN'S HOSPITAL MA $360,256
Hepatitis - C 2018 NIAID 5R01AI127469-02 Molecular and structural characterization of broadly neutralizing anti-HCV antibodies BAILEY, JUSTIN JOHNS HOPKINS UNIVERSITY MD $719,898
Hepatitis - C 2018 NIDA 5R01DA043409-02 Integrating Assisted Partner Services and Phylogenetics for HIV and HCV Prevention HERBECK, JOSHUA UNIVERSITY OF WASHINGTON WA $622,753
Hepatitis - C 2018 NCI 5UG3CA211551-02 Field-deployable platform for prognostic hepatic cancer screening in low-resource settings PORTER, MARC UNIVERSITY OF UTAH UT $403,427
Hepatitis - C 2018 OD 5R01DA044135-02 Regulatory T cell dysfunction in HIV-1/HCV drug users LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $199,650
Hepatitis - C 2018 NCATS 5KL2TR001441-04 UTMB Clinical and Translational Science Award AMEREDES, BILL UNIVERSITY OF TEXAS MED BR GALVESTON TX $423,431
Hepatitis - C 2018 NIAID 1R01AI136626-01 Changes in Bone Quality, Sarcopenia and Fat Distribution in HIV/HCV Patients after HCV Therapy LO RE, VINCENT UNIVERSITY OF PENNSYLVANIA PA $814,787
Hepatitis - C 2018 NHGRI 5RM1HG009038-03 Ethical, Legal and Social Issues for Precision Medicine and Infectious Disease GELLER, GAIL JOHNS HOPKINS UNIVERSITY MD $1,110,370
Hepatitis - C 2018 NIDA 1K01DA045618-01A1 Medicaid Prior Authorization Policies for Chronic Hepatitis C Treatment in Vulnerable Populations PARK, HAESUK UNIVERSITY OF FLORIDA FL $130,041
Hepatitis - C 2018 NIDA 1K23DA044085-01A1 Engaging Young People who Inject Drugs into HCV and HIV Care ASSOUMOU, SABRINA BOSTON MEDICAL CENTER MA $190,960
Hepatitis - C 2018 NIAID 1R01AI136715-01 HIV, HCV, Hippo, and Liver Disease Progression CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $792,339
Hepatitis - C 2018 NCI 5R21CA209940-02 Integrative genomic framework for dissecting regulatory mechanisms underlying hepatocellular carcinoma POCHET, NATHALIE BRIGHAM AND WOMEN'S HOSPITAL MA $175,001
Hepatitis - C 2018 NIAID 5U19AI082630-10 7590 Restoration of Innate Immunity with Viral Cure CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $481,305
Hepatitis - C 2018 NIAID 5U19AI082630-10 7591 Mechanisms of Restoring T Cell Immunity after Cure of Chronic Viral Infection LAUER, GEORG MASSACHUSETTS GENERAL HOSPITAL MA $482,876
Hepatitis - C 2018 NIAID 5U19AI082630-10 7592 Epigenetic Plasticity of HCV-Specific CD8 T Cells after Antiviral Therapy HAINING, WILLIAM DANA-FARBER CANCER INST MA $414,354
Hepatitis - C 2018 NIAID 5U19AI082630-10 7593 Induction and Recovery of T Cells after Cure of Chronic Viral Infection KLENERMAN, PAUL UNIVERSITY OF OXFORD UK $249,999
Hepatitis - C 2018 NIAID 5U19AI082630-10 7594 Administrative Core CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $173,225
Hepatitis - C 2018 NIAID 5U19AI082630-10 7595 Pilot/Feasibility Studies Program CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $84,249
Hepatitis - C 2018 NIAID 5U19AI082630-10 7596 Tissue and Clinical Core KIM, ARTHUR MASSACHUSETTS GENERAL HOSPITAL MA $284,556
Hepatitis - C 2018 NIAID 5U19AI082630-10 7597 Virology Core ALLEN, TODD MASSACHUSETTS GENERAL HOSPITAL MA $106,547
Hepatitis - C 2018 NIAID 5K01AI122853-04 Optimizing Care for HIV/HCV-Coinfected Patients in the New HCV Treatment Era MARCUS, JULIA HARVARD PILGRIM HEALTH CARE, INC. MA $144,850
Hepatitis - C 2018 NIGMS 5U01GM110749-06 Modeling Epidemic Infectious Diseases Using Sequence Analysis POND, SERGEI TEMPLE UNIV OF THE COMMONWEALTH PA $574,951
Hepatitis - C 2018 NIMH 5R01MH105319-04 Brain Amyloid and HAND in the cART era ACHIM, CRISTIAN UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $475,752
Hepatitis - C 2018 NCI 1R01CA228589-01 Understanding the Determinants of Racial/Ethnic Disparities in Liver Cancer and Chronic Liver Disease in Understudied and High-Risk Populations SETIAWAN, VERONICA UNIVERSITY OF SOUTHERN CALIFORNIA CA $601,819
Hepatitis - C 2018 NIDA 5R01DA036514-05 Evaluating a Microfinance Intervention for High Risk Women in Kazakhstan EL-BASSEL, NABILA COLUMBIA UNIV NEW YORK MORNINGSIDE NY $654,246
Hepatitis - C 2018 NIDA 5R01DA041501-03 The Staying Safe Intervention: Preventing HCV among Young Opioid Injectors MATEU-GELABERT, PEDRO NATIONAL DEVELOPMENT & RES INSTITUTES NY $739,640
Hepatitis - C 2018 NIDA 5R37DA013806-19 HIV HCV Coinfection Antiviral Therapy and Fibrosis THOMAS, DAVID JOHNS HOPKINS UNIVERSITY MD $733,577
Hepatitis - C 2018 NCI 5R01CA206465-03 (PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer JUSTICE, AMY YALE UNIVERSITY CT $512,833
Hepatitis - C 2018 NIDA 5R01DA039775-04 Impact of HCV Therapy on CNS Outcomes BHARTI, AJAY UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $419,180
Hepatitis - C 2018 NIDA 5R01DA040499-04 Antiviral pharmacology and adherence in drug users KISER, JENNIFER UNIVERSITY OF COLORADO DENVER CO $521,567
Hepatitis - C 2018 NIAID 5R01AI125416-03 Defining the role of the RNA modification N6-methyladenosine in the hepatitis C virus lifecycle HORNER, STACY DUKE UNIVERSITY NC $489,059
Hepatitis - C 2018 NIAID 5F32AI126892-03 The role of epistatic networks in shaping adaptive landscapes ACEVEDO, ASHLEY ROCKEFELLER UNIVERSITY NY $61,174
Hepatitis - C 2018 OD 5R01OD011095-26 Modeling Viral and T Lymphocyte Dynamics PERELSON, ALAN LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB NM $444,412
Hepatitis - C 2018 NIAID 5R01AI132213-02 Structure-Based Vaccine Design for Hepatits C Virus FUERST, THOMAS UNIV OF MARYLAND, COLLEGE PARK MD $1,142,860
Hepatitis - C 2018 NHLBI 5K23HL133358-02 Elucidating Hepatitis C Infection as a Risk Factor for Coronary Heart Disease in HIV-Infected Patients BAGCHI, SHASHWATEE UNIVERSITY OF MARYLAND BALTIMORE MD $182,354
Hepatitis - C 2018 NIAID 5K23AI108355-04 Quantitative Pharmacology for Accelerating Drug Development for HIV/HCV Co-Infected Patients VENUTO, CHARLES UNIVERSITY OF ROCHESTER NY $138,978
Hepatitis - C 2018 NIDA 5R01DA040449-04 Impact on opioid use of bundling medication-assisted treatment with mHealth GUSTAFSON, DAVID UNIVERSITY OF WISCONSIN-MADISON WI $666,182
Hepatitis - C 2018 NIAID 5R01AI126890-03 T cell Immunity and the Outcome of Acute HCV Infection WALKER, CHRISTOPHER RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $745,107
Hepatitis - C 2018 NIDA 5U01DA040381-03 Cohort Studies on HIV/AIDS and Substance Abuse in Miami BAUM, MARIANNA FLORIDA INTERNATIONAL UNIVERSITY FL $1,077,827
Hepatitis - C 2018 NIDA 5R01DA041736-03 Individual, Network and Spatial Drivers of HIV and HCV among PWID in India SOLOMON, SUNIL JOHNS HOPKINS UNIVERSITY MD $954,451
Hepatitis - C 2018 NIDA 5UG1DA013035-17 NIDA Clinical Trials Network: Greater New York Node ROTROSEN, JOHN NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $773,828
Hepatitis - C 2018 NCI 1U01CA225753-01 Screening of Glycan Markers in Serum for Early Detection of HCC in Different Etiologies of Disease LUBMAN, DAVID UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $529,478
Hepatitis - C 2018 NIDA 1R01DA044971-01A1 Effects of State Laws to Reduce Opioid Diversion on Transitions to Injection Drug Use and HIV/HCV Transmission DICKSON-GOMEZ, JULIA MEDICAL COLLEGE OF WISCONSIN WI $652,675
Hepatitis - C 2018 NIDA 5UG1DA015815-17 Western States Node of the National Drug Abuse Treatment Clinical Trials Network SORENSEN, JAMES UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $679,225
Hepatitis - C 2018 NIDA 5R21DA044807-02 Examining the social, spatial, and temporal context of injection drug use and HIV and HCV risk among people who inject drugs in Ukraine OWCZARZAK, JILL JOHNS HOPKINS UNIVERSITY MD $204,688
Hepatitis - C 2018 NIDDK 1K23DK117014-01 Effect of Hepatitis C Virus Eradication on Chronic Kidney Disease Progression SISE, MEGHAN MASSACHUSETTS GENERAL HOSPITAL MA $174,100
Hepatitis - C 2018 NIDDK 5R21DK108045-02 Waiting List and Kidney Transplant Outcomes for Patients with Hepatitis C Infection REESE, PETER UNIVERSITY OF PENNSYLVANIA PA $202,679
Hepatitis - C 2018 NIAID 5K08AI119142-05 Role of Ire1alpha in Resistance to Viral-Induced Apoptosis FINK, SUSAN UNIVERSITY OF WASHINGTON WA $187,312
Hepatitis - C 2018 NIDA 1R34DA045856-01 Re-entry XR-NTX for rural opioid dependent women STATON, MICHELE UNIVERSITY OF KENTUCKY KY $186,920
Hepatitis - C 2018 NIDA 5R01DA037117-05 Injection Risk Networks in Rural Puerto Rico DOMBROWSKI, KIRK UNIVERSITY OF NEBRASKA LINCOLN NE $453,745
Hepatitis - C 2018 NIDDK 5R01DK088787-08 HCV Entry: Mechanisms and Therapeutics STEIN, PAUL SRI INTERNATIONAL CA $605,012
Hepatitis - C 2018 NIAID 1R01AI137567-01 Host response and liver disease in a hepatitis C-like virus rat model KAPOOR, AMIT RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $543,426
Hepatitis - C 2018 NCI 5R01CA188506-04 Dissection of Pten-regulated signals in hepatopathogenesis FENG, GEN-SHENG UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $404,404
Hepatitis - C 2018 NIDA 5K23DA041294-03 The impact of social networks on hepatitis C transmission and care access in people who inject drugs FALADE-NWULIA, OLUWASEUN JOHNS HOPKINS UNIVERSITY MD $190,337
Hepatitis - C 2018 NCI 5R01CA160254-07 Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach LUBMAN, DAVID UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $360,861
Hepatitis - C 2018 NIDA 5R01DA041298-03 Accessible Care Intervention for Engaging People who Inject Illicit Drugs (PWID) in Hepatitis C Care MATEU-GELABERT, PEDRO NATIONAL DEVELOPMENT & RES INSTITUTES NY $557,431
Hepatitis - C 2018 NCI 1R21CA215883-01A1 Assessment of gene expression profiles related to hepatocellular carcinoma in HCV: singlecell hepatocyte sequencing as a tool to identify cancer-related genes DEBES, JOSE UNIVERSITY OF MINNESOTA MN $167,385
Hepatitis - C 2018 NIDA 5K01DA037802-05 Understanding the interpersonal context of HIV/HCV risk within injecting dyads MORRIS, MEGHAN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $182,587
Hepatitis - C 2018 NCI 5F30CA180731-04 TCR Gene Transfer for Treating HCV-Associated Malignancies SPEAR, TIMOTHY LOYOLA UNIVERSITY CHICAGO IL $49,524
Hepatitis - C 2018 NIDDK 5R01DK081817-08 HCV infection, cross-talk among liver cells, and liver disease progression RAY, RATNA SAINT LOUIS UNIVERSITY MO $340,875
Hepatitis - C 2018 NIDA 5K24DA037034-05 Mentoring and Empowerment in the Context of HIV Care for At-Risk Populations JOHNSON, MALLORY UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $183,707
Hepatitis - C 2018 NCI 5U01AI069918-13 North American AIDS Cohorts Collaboration on Research and Design (NAACCORD) Renewal MOORE, RICHARD JOHNS HOPKINS UNIVERSITY MD $356,764
Hepatitis - C 2018 NIA 5U01AI069918-13 North American AIDS Cohorts Collaboration on Research and Design (NAACCORD) Renewal MOORE, RICHARD JOHNS HOPKINS UNIVERSITY MD $309,335
Hepatitis - C 2018 NIAID 5U01AI069918-13 North American AIDS Cohorts Collaboration on Research and Design (NAACCORD) Renewal MOORE, RICHARD JOHNS HOPKINS UNIVERSITY MD $2,192,433
Hepatitis - C 2018 NIDA 5U01AI069918-13 North American AIDS Cohorts Collaboration on Research and Design (NAACCORD) Renewal MOORE, RICHARD JOHNS HOPKINS UNIVERSITY MD $202,093
Hepatitis - C 2018 NIAAA 5R01AA023726-05 Comparing Brief Alcohol Interventions for HIV-HCV Co-infected Persons STEIN, MICHAEL BUTLER HOSPITAL (PROVIDENCE, RI) RI $480,822
Hepatitis - C 2018 NIAID 2R01AI107301-06 Genetic Viral and Host Adaptations to Breach Species Barriers of HCV PLOSS, ALEXANDER PRINCETON UNIVERSITY NJ $506,524
Hepatitis - C 2018 NIDA 5R34DA041465-03 Facilitating treatment entry and family planning in substance-using NICU mothers STOTTS, ANGELA UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $231,000
Hepatitis - C 2018 NIDA 5R01DA043130-03 A Cluster RCT to Increase HIV Testing in Substance Use Treatment Programs METSCH, LISA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $1,632,719
Hepatitis - C 2018 NIAID 5U01AI131314-03 Immune Control and Evadion during Acute HCV Infection LAUER, GEORG MASSACHUSETTS GENERAL HOSPITAL MA $276,000
Hepatitis - C 2018 NIDA 5R13DA040427-04 Dissemination and implementation of evidenced based treatments for substance abuse disorders and HIV for justice involved populations FERGUSON, WARREN UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $25,511
Hepatitis - C 2018 NIAID 1R21AI133250-01A1 Development of a hepatitis C virus vaccine using papillomavirus-like particles for antigen delivery QIAO, LIANG LOYOLA UNIVERSITY CHICAGO IL $182,975
Hepatitis - C 2018 NIDA 5R01DA040506-04 A randomised study of interferon-free treatment for recently acquired hepatitis C in people who inject drugs and people with HIV coinfection (the REACT Study) MATTHEWS, GAIL UNIVERSITY OF NEW SOUTH WALES AUSTRA $964,605
Hepatitis - C 2018 NIDA 5R01DA013324-20 HIV and Hepatitis C Pathogenesis & The Human Genome THOMAS, DAVID JOHNS HOPKINS UNIVERSITY MD $720,712
Hepatitis - C 2018 NIAID 5F32AI126660-03 RNA-Protein Interactions During Hepatitis C Virus Infection ADAMS, REBECCA YALE UNIVERSITY CT $61,174
Hepatitis - C 2018 NIAID 5R01AI071068-13 Acute/chronic limitations to transcriptional RNAi therapies for infectious and other liver diseases KAY, MARK STANFORD UNIVERSITY CA $481,343
Hepatitis - C 2018 NIAID 5R01AI131518-02 Hepatitis C virus genome structure: dynamic roles in replication and infectivity PYLE, ANNA YALE UNIVERSITY CT $596,514
Hepatitis - C 2018 NIAID 5F31AI126863-03 Host and viral determinants of hepatitis C virus species tropism GRAY, ESSANNA ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $39,744
Hepatitis - C 2018 NIAID 5R01AI123136-03 Flavivirus non-coding RNAs and the Host mRNA Decay Machinery WILUSZ, JEFFREY COLORADO STATE UNIVERSITY CO $372,709
Hepatitis - C 2018 NIDA 5K99DA043011-02 Advance Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants Living with Hepatitis C-The HCV-ACCELERATE Trial AKIYAMA, MATTHEW ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $184,734
Hepatitis - C 2018 NIAID 5R21AI124923-02 Immune correlates of HAART-mediated spontaneous control of chronic HCV infection OSBURN, WILLIAM JOHNS HOPKINS UNIVERSITY MD $204,688
Hepatitis - C 2018 NIAID 5U01AI131313-03 T Cell Immunity and HCV Infection Outcome WALKER, CHRISTOPHER RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $273,372
Hepatitis - C 2018 NIAID 1F31AI131477-01A1 Novel Regulatory Controls of Hepatitis C Virus Envelopment and Secretion by the Viral NS4A Protein RODER, ALLISON DUKE UNIVERSITY NC $36,166
Hepatitis - C 2018 NIGMS 5R01GM121600-02 Computational discovery of effective hepatitis C intervention strategies DAHARI, HAREL LOYOLA UNIVERSITY CHICAGO IL $397,037
Hepatitis - C 2018 NIGMS 5R35GM119634-03 Understanding Evolution of Protein Function Through Design. KORENDOVYCH, IVAN SYRACUSE UNIVERSITY NY $375,000
Hepatitis - C 2018 NIAID 5R33AI116228-05 Targeting HIV-1 persistence with Interferon-a YU, XU MASSACHUSETTS GENERAL HOSPITAL MA $513,000
Hepatitis - C 2018 NIDA 5UG3DA044830-02 Drug Injection Surveillance and Care Enhancement for Rural Northern New England (DISCERNNE) FRIEDMANN, PETER BAYSTATE MEDICAL CENTER MA $548,410
Hepatitis - C 2018 NIDA 5UG3DA044831-02 Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study KORTHUIS, PHILIP OREGON HEALTH & SCIENCE UNIVERSITY OR $401,402
Hepatitis - C 2018 NIDA 5R01DA043484-02 Contextual risk factors for hepatitis C among young persons who inject drugs BOODRAM, BASMATTEE UNIVERSITY OF ILLINOIS AT CHICAGO IL $647,748
Hepatitis - C 2018 NIDA 5U24DA044801-02 Next-Generation Sequencing Center for GHOSTing Hepatitis C Virus: Transforming Community Based Molecular Surveillance and Outbreak Investigation ALLEN, TODD MASSACHUSETTS GENERAL HOSPITAL MA $595,373
Hepatitis - C 2018 NIDA 5UG3DA044798-02 Kentucky Communities and Researchers Engaging to Halt the Opioid Epidemic (CARE2HOPE) YOUNG, APRIL UNIVERSITY OF KENTUCKY KY $194,315
Hepatitis - C 2018 NIDA 5UG3DA044826-02 Community-based, client-centered prevention homes to address the rural opioid epidemic WESTERGAARD, RYAN UNIVERSITY OF WISCONSIN-MADISON WI $584,925
Hepatitis - C 2018 NIDA 5UG3DA044822-02 Implementing a Community-Based Response to the Opioid Epidemic in Rural Ohio MILLER, WILLIAM OHIO STATE UNIVERSITY OH $556,071
Hepatitis - C 2018 NIDA 5UG3DA044829-02 Ending transmission of HIV, HCV, and STDs and overdose in rural communities of people who inject drugs (ETHIC) PHO, MAI UNIVERSITY OF CHICAGO IL $542,423
Hepatitis - C 2018 NIDA 5UG3DA044823-02 Mitigating the Outcomes Associated with the Injection Drug Use Epidemic in Southern Appalachia ZULE, WILLIAM RESEARCH TRIANGLE INSTITUTE NC $535,101
Hepatitis - C 2018 NIDA 5UG3DA044825-02 Rural West Virginia Responds to Opioid Injection Epidemics: From Data to Action FEINBERG, JUDITH WEST VIRGINIA UNIVERSITY WV $110,037
Hepatitis - C 2018 NIDA 5R01DA016017-16 Acute Hepatitis C Infection in Young Injectors PAGE, KIMBERLY UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR NM $1,268,832
Hepatitis - C 2018 NIDDK 5R01DK108362-04 Hepatitis E in HIV-Infected Patients SHERMAN, KENNETH UNIVERSITY OF CINCINNATI OH $274,999
Hepatitis - C 2018 NIDDK 5R01DK108364-04 HIV and hepatic inflammation and fibrosis BANSAL, MEENA ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $212,000
Hepatitis - C 2018 NIDA 5K23DA039060-04 Adaptation and testing of a primary care HCV group medical treatment intervention NORTON, BRIANNA ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $197,640
Hepatitis - C 2018 NIAAA 5R01AA025204-02 NANOG-positive cancer stem cells in liver oncogenesis induced by alcohol and HCV MACHIDA, KEIGO UNIVERSITY OF SOUTHERN CALIFORNIA CA $371,250
Hepatitis - C 2018 FIC 5U54CA221205-02 6392 Administrative Core HOU, LIFANG NORTHWESTERN UNIVERSITY AT CHICAGO IL $11,961
Hepatitis - C 2018 NCI 5U54CA221205-02 6392 Administrative Core HOU, LIFANG NORTHWESTERN UNIVERSITY AT CHICAGO IL $81,881
Hepatitis - C 2018 FIC 5U54CA221205-02 6394 Biomedical Informatics and Statistics Core LIU, LEI NORTHWESTERN UNIVERSITY AT CHICAGO IL $16,216
Hepatitis - C 2018 NCI 5U54CA221205-02 6394 Biomedical Informatics and Statistics Core LIU, LEI NORTHWESTERN UNIVERSITY AT CHICAGO IL $111,008
Hepatitis - C 2018 NIDDK 5R01DK108370-04 HIV-Associated Macrophage Alterations and Progressive Liver Disease CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $325,001
Hepatitis - C 2018 NIDDK 5K23DK101827-04 Bacterial Translocation and the Intestinal Microbiome in Recurrent Disease Following Liver Transplantation VERNA, ELIZABETH COLUMBIA UNIVERSITY HEALTH SCIENCES NY $167,724
Hepatitis - C 2018 NIAAA 5U01AA020790-08 2/6 COMpAAAS U01: Observation Study JUSTICE, AMY YALE UNIVERSITY CT $1,004,763
Hepatitis - C 2018 NIAAA 5U24AA020794-08 1/6 COMpAAAS U24: Coordinating Center JUSTICE, AMY YALE UNIVERSITY CT $234,253
Hepatitis - C 2018 NIDA 5R01DA043396-02 Immune correlates of long-term success with DAA therapy in HCV/HIV infected people who inject drugs KOTTILIL, SHYAMASUNDARAN UNIVERSITY OF MARYLAND BALTIMORE MD $371,083
Hepatitis - C 2018 NIAID 1R43AI138882-01 Development of a simple and robust point-of-care test for detection of Hepatitis C RNA from finger prick whole blood in resource-limited settings LEE, HELEN DIAGNOSTICS FOR THE REAL WORLD, LTD CA $143,627
Hepatitis - C 2018 NIDA 2K24DA034621-06 Midcareer Investigator Award in Patient-Oriented Research (Parent K24) SULKOWSKI, MARK JOHNS HOPKINS UNIVERSITY MD $122,036
Hepatitis - C 2018 NIDA 1R01DA046277-01 T cells in HCV/HIV co-infection LAUER, GEORG MASSACHUSETTS GENERAL HOSPITAL MA $648,499
Hepatitis - C 2018 NIAAA 5U01AA020799-08 4/6 COMpAAAS U01: Operations Research Study BRAITHWAITE, RONALD NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $197,206
Hepatitis - C 2018 NIDA 5R01DA045556-02 Building on Needle Exchange to Optimize HIV Prevention/Treatment LUCAS, GREGORY JOHNS HOPKINS UNIVERSITY MD $880,508
Hepatitis - C 2018 NIAAA 5U01AA026230-02 2/3 COMpAAAS Tripartite: ART-CC, KP, and VA SILVERBERG, MICHAEL KAISER FOUNDATION RESEARCH INSTITUTE CA $592,224
Hepatitis - C 2018 OD 5R01AA025882-02 Computer-based Alcohol Reduction Intervention for alcohol-using HIV/HCV+ Russian women in Clinical Care DICLEMENTE, RALPH EMORY UNIVERSITY GA $196,832
Hepatitis - C 2018 NIAID 1U01AI138897-01 HOPE in Action: A Clinical Trial of HIV-to-HIV Liver Transplantation DURAND, CHRISTINE JOHNS HOPKINS UNIVERSITY MD $1,778,541
Hepatitis - C 2018 FIC 5U54CA190165-05 7861 The Role of HIV Infection in the Etiology and Clinical Manifestations of Hep Carcinoma KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $11,941
Hepatitis - C 2018 NCI 5U54CA190165-05 7861 The Role of HIV Infection in the Etiology and Clinical Manifestations of Hep Carcinoma KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $206,457
Hepatitis - C 2018 FIC 5U54CA190165-05 7862 Pre Malignant Cirrhosis and Hepatocellular Carcinoma in HIV Infected Ugandans KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $14,839
Hepatitis - C 2018 NCI 5U54CA190165-05 7862 Pre Malignant Cirrhosis and Hepatocellular Carcinoma in HIV Infected Ugandans KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $256,559
Hepatitis - C 2018 NIDA 5R34DA043957-02 Preventing Injection: An mHealth intervention that leverages social networks to prevent progression to injection among young opioid users ACOSTA, MICHELLE NATIONAL DEVELOPMENT & RES INSTITUTES NY $345,375
Hepatitis - C 2018 NIDDK 5R01DK110024-02 Epigenetic Mechanisms Underlying Hepatitis C-Induced Hepatocarcinogenesis ROBERTSON, KEITH MAYO CLINIC ROCHESTER MN $601,776
Hepatitis - C 2018 NHLBI 5R21HL140269-02 Origin and evolution of virome in development of post-transfusion hepatitis KAPOOR, AMIT RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $114,000
Hepatitis - C 2018 NIDDK 5K23DK109294-02 Factors Responsible for Liver Recovery After Successful Treatment of Hepatitis C. DUNN, WINSTON UNIVERSITY OF KANSAS MEDICAL CENTER KS $199,800
Hepatitis - C 2018 NIAAA 5U01AA026224-02 3/3 COMpAAAS Tripartite: ART-CC, KP, and VA JUSTICE, AMY YALE UNIVERSITY CT $591,994
Hepatitis - C 2018 NIAAA 5U01AA026209-02 1/3 Collaborative Research in HIV/AIDS, Alcohol, and Related Comorbidities (COMpAAAS) Tripartite: ART-CC, KP, and VA MAY, MARGARET UNIVERSITY OF BRISTOL UK $433,824
Hepatitis - C 2018 NIAID 1R01AI134611-01A1 Structural Basis for Antiviral Drug Mitochondrial Toxicity YIN, YUHUI UNIVERSITY OF TEXAS MED BR GALVESTON TX $390,013
Hepatitis - C 2018 NIDA 5R01DA045713-02 A Multi-site Multi-Setting RCT of Integrated HIV Prevention and HCV Care for PWID METSCH, LISA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $2,124,322
Hepatitis - C 2018 NIDA 5R21DA044251-02 Examining Social Influences on Syringe Exchange Uptake among Rural PWID at Risk for HIV SURRATT, HILARY UNIVERSITY OF KENTUCKY KY $179,109
Hepatitis - C 2018 NIAID 1R21AI139012-01 Mitochondrial-Nuclear Genetic Interactions in Spontaneous HCV Clearance HULGAN, TODD VANDERBILT UNIVERSITY MEDICAL CENTER TN $288,869
Hepatitis - C 2018 NIMHD 3U01MD010614-03S1 Increasing Uptake of Evidence Based Screening Services though a CHW-led multi-modality program: The South Florida Center for Reducing Health Disparities CARRASQUILLO, OLVEEN UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $148,818
Hepatitis - C 2018 NIAID 1R03AI139835-01 Enhanced Virome Sequencing in Human Blood FAN, XIAOFENG SAINT LOUIS UNIVERSITY MO $75,750
Hepatitis - C 2018 NIAID 1R21AI139954-01 Impact of Occult Hepatitis C Virus Infection in Progression of Liver Diseases SAITO, TAKESHI UNIVERSITY OF SOUTHERN CALIFORNIA CA $288,750
Hepatitis - C 2018 NIAID 1R38AI140299-01 Emory R38 Research Training Program OFOTOKUN, IGHOVWERHA EMORY UNIVERSITY GA $344,760
Hepatitis - C 2018 NIAID 1R01AI134980-01A1 Elucidating How Tri-phosphatase DUSP11 Controls HCV Infection and Hepatocyte Inflammation SULLIVAN, CHRISTOPHER UNIVERSITY OF TEXAS, AUSTIN TX $482,028
Hepatitis - C 2018 NIAID 2R01AI096882-06 Persistent hepatitis C virus replication and immunity in pregnancy WALKER, CHRISTOPHER RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $641,271
Hepatitis - C 2018 NCI 3R01CA186566-04S1 Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC) HASSAN, MANAL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $165,134
Hepatitis - C 2018 NIAID 2R01AI069000-11 Roles for microRNA-122 and circular RNAs in flavivirus RNA amplification SARNOW, PETER STANFORD UNIVERSITY CA $549,500
Hepatitis - C 2018 NIDA 3R01DA025885-10S1 Sustainable HIV Risk Reduction Strategies for CJ Systems LEHMAN, WAYNE TEXAS CHRISTIAN UNIVERSITY TX $78,173
Hepatitis - C 2018 NIDA 1R21DA045293-01A1 Developing Typologies of Semi-Rural and Suburban Localities to Understandthe Epidemiology of Prescription Opioid Misuse GAINES, TOMMI UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $247,049
Hepatitis - C 2018 NIAID 1R21AI140499-01 Myeloid cell IFNGR regulation in persistent viral and secondary bacterial infections LENZ, LAUREL UNIVERSITY OF COLORADO DENVER CO $229,828
Hepatitis - C 2018 NIAAA 1R01AA027179-01 Epigenetic Heterogeneity as a Driver of Liver Disease and Cancer ROBERTSON, KEITH MAYO CLINIC ROCHESTER MN $520,900
Hepatitis - C 2018 NIDA 3R01DA037117-05S1 Injection Risk Networks in Rural Puerto Rico DOMBROWSKI, KIRK UNIVERSITY OF NEBRASKA LINCOLN NE $241,122
Hepatitis - C 2018 NIAID 5U19AI123861-03 6292 Administrative Core LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $172,727
Hepatitis - C 2018 NIAID 5U19AI123861-03 6293 Antibody responses to HCV vaccine antigens in infection and vaccination LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $429,801
Hepatitis - C 2018 NIAID 5U19AI123861-03 6294 Novel HCV vaccine antigens targeting conserved neutralizing epitopes ZHU, JIANG SCRIPPS RESEARCH INSTITUTE CA $316,208
Hepatitis - C 2018 NIAID 5U19AI109662-05 7133 Haploid genetic screen to identify host genes required for RNA virruses GLENN, JEFFREY STANFORD UNIVERSITY CA $448,661
Hepatitis - C 2018 NIAID 5U19AI109662-05 7134 Computation and Repurposing to identfy antivirals directed against dominant PANDE, VIJAY STANFORD UNIVERSITY CA $763,571
Hepatitis - C 2018 NIAID 5U19AI109662-05 7135 Novel Interferons and small molecule enhancers of the interferon pathway GARCIA, KENAN STANFORD UNIVERSITY CA $529,779
Hepatitis - C 2018 NIAID 5U19AI111825-05 7689 Effects of Persistent Innate Immune Activation on Vaccine Efficacy RICE, CHARLES ROCKEFELLER UNIVERSITY NY $541,028
Hepatitis - C 2018 NIDA 3R01DA043409-02S1 Integrating Assisted Partner Services and Phylogenetics for HIV and HCV Prevention HERBECK, JOSHUA UNIVERSITY OF WASHINGTON WA $71,547
Hepatitis - C 2018 NCI 261201200042I-5-26100006-1 PHASEI/II TRIAL OF A THERAPEUTIC DNA VACCINE FOR CHRONIC HEPATITIS C VIRUS (HCV) INFECTION; LIMBURG, PAUL MAYO CLINIC ROCHESTER MN $170,562
12


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer